270 related articles for article (PubMed ID: 35687217)
1. PI3K/AKT/mTOR signalling inhibitor chrysophanol ameliorates neurobehavioural and neurochemical defects in propionic acid-induced experimental model of autism in adult rats.
Sharma A; Bhalla S; Mehan S
Metab Brain Dis; 2022 Aug; 37(6):1909-1929. PubMed ID: 35687217
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage.
Jadaun KS; Mehan S; Sharma A; Siddiqui EM; Kumar S; Alsuhaymi N
Curr Med Sci; 2022 Apr; 42(2):249-266. PubMed ID: 35079960
[TBL] [Abstract][Full Text] [Related]
3. Smo-Shh signaling activator purmorphamine ameliorates neurobehavioral, molecular, and morphological alterations in an intracerebroventricular propionic acid-induced experimental model of autism.
Rahi S; Gupta R; Sharma A; Mehan S
Hum Exp Toxicol; 2021 Nov; 40(11):1880-1898. PubMed ID: 33906504
[TBL] [Abstract][Full Text] [Related]
4. Guggulsterone Mediated JAK/STAT and PPAR-Gamma Modulation Prevents Neurobehavioral and Neurochemical Abnormalities in Propionic Acid-Induced Experimental Model of Autism.
Khera R; Mehan S; Bhalla S; Kumar S; Alshammari A; Alharbi M; Sadhu SS
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164154
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Chrysophanol as a PI3K/AKT/mTOR Signaling Inhibitor in an Experimental Model of Autologous Blood-induced Intracerebral Hemorrhage.
Jadaun KS; Mehan S; Sharma A; Siddiqui EM; Kumar S; Alsuhaymi N
Curr Med Sci; 2022 Jan; ():. PubMed ID: 35099677
[TBL] [Abstract][Full Text] [Related]
6. 4-hydroxyisoleucine mediated IGF-1/GLP-1 signalling activation prevents propionic acid-induced autism-like behavioural phenotypes and neurochemical defects in experimental rats.
Bhalla S; Mehan S
Neuropeptides; 2022 Dec; 96():102296. PubMed ID: 36307249
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effect of α-Mangostin in the Ameliorating Propionic Acid-Induced Experimental Model of Autism in Wistar Rats.
Tiwari A; Khera R; Rahi S; Mehan S; Makeen HA; Khormi YH; Rehman MU; Khan A
Brain Sci; 2021 Feb; 11(3):. PubMed ID: 33669120
[TBL] [Abstract][Full Text] [Related]
8. mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.
Thomas SD; Jha NK; Ojha S; Sadek B
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838876
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder.
Zhang J; Zhang JX; Zhang QL
Brain Res Bull; 2016 Jul; 125():152-8. PubMed ID: 27320472
[TBL] [Abstract][Full Text] [Related]
10. Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway.
Jian J; Li LG; Zhao PJ; Zheng RJ; Dong XW; Zhao YH; Yin BQ; Li S; Cheng H; Li HL; Li EY
Pharmacogenet Genomics; 2023 Jul; 33(5):101-110. PubMed ID: 37261937
[TBL] [Abstract][Full Text] [Related]
11. Targeting PI3K-AKT/mTOR signaling in the prevention of autism.
Sharma A; Mehan S
Neurochem Int; 2021 Jul; 147():105067. PubMed ID: 33992742
[TBL] [Abstract][Full Text] [Related]
12. Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats.
Mirza R; Sharma B
Life Sci; 2018 Dec; 214():106-117. PubMed ID: 30366038
[TBL] [Abstract][Full Text] [Related]
13. IL-6 Enhances the Activation of PI3K-AKT/mTOR-GSK-3β by Upregulating GRPR in Hippocampal Neurons of Autistic Mice.
Li H; Wang X; Hu C; Cui J; Li H; Luo X; Hao Y
J Neuroimmune Pharmacol; 2024 Mar; 19(1):12. PubMed ID: 38536552
[TBL] [Abstract][Full Text] [Related]
14. Dingkun Pill replenishes diminished ovarian reserve through the PI3K/AKT/mTOR signaling pathway in TWP-induced mice.
Ma K; Chen Y; Fan X; Yuan Y; Wang K; Tian C; Li M
J Ethnopharmacol; 2020 Nov; 262():112993. PubMed ID: 32473368
[TBL] [Abstract][Full Text] [Related]
15. Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway.
Zheng M; Liu Z; Mana L; Qin G; Huang S; Gong Z; Tian M; He Y; Wang P
J Ethnopharmacol; 2021 Oct; 278():114264. PubMed ID: 34082015
[TBL] [Abstract][Full Text] [Related]
16. Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis.
Upadhayay S; Mehan S; Prajapati A; Sethi P; Suri M; Zawawi A; Almashjary MN; Tabrez S
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893061
[TBL] [Abstract][Full Text] [Related]
17. Lycopene ameliorates propionic acid-induced autism spectrum disorders by inhibiting inflammation and oxidative stress in rats.
Erten F
J Food Biochem; 2021 Oct; 45(10):e13922. PubMed ID: 34476820
[TBL] [Abstract][Full Text] [Related]
18. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.
Xing X; Zhang J; Wu K; Cao B; Li X; Jiang F; Hu Z; Xia K; Li JD
Sci Rep; 2019 Feb; 9(1):3041. PubMed ID: 30816216
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders.
Bhandari R; Kuhad A
Life Sci; 2015 Nov; 141():156-69. PubMed ID: 26407474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
